RDIF and Panacea Biotec agree to produce 100 million doses of Sputnik V vaccine in India per year
Posted On: 2021-04-05 09:45:51 (Time Zone: Arizona, USA)
The Russian Direct Investment Fund (RDIF, Russia s sovereign wealth fund), and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India, announce cooperation to produce 100 million doses per year of Sputnik V, the world s first registered vaccine against coronavirus. Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.
To date Sputnik V has been registered in 59 countries globally with total population of over 1.5 billion people. Efficacy of Sputnik V is 91.6% as confirmed by the data published in the Lancet, one of the world s oldest and most respected medical journals.
Technical View - April 5, 2021 - Mr. Nagaraj Shetti, Technical Research Analyst, HDFC Securities
Posted On: 2021-04-05 09:48:09 (Time Zone: Arizona, USA)
After showing a sustainable upside bounce on Thursday, Nifty witnessed sharp fall on Monday and closed the day lower by 229 points amidst a recovery from the lows. Nifty opened on a negative note, witnessed steep intraday sell off in the early part of the session. A sustainable upside recovery has emerged from a day s low of 14459 and Nifty finally closed the day by erasing some of intraday loss.
A long negative candle was formed on Monday on the daily chart with lower shadow. This indicate a sharp profit booking from the highs-resistance and the emergence of buying from the lower supports. The crucial overhead resistance of around 14880 has proved to be a tough task for the market as of now (resistance as per change in polarity), we observe that the market not able to sustain above this hurdle for the second occasions rec